Madame Bioscience Public Company Limited Holds Extraordinary General Meeting

The Stock Exchange of Thailand's announcement highlights the important decisions made by Madame Bioscience Public Company Limited (the "Company") during its Extraordinary General Meeting of Shareholders No. 3/2025. On September 19, 2025, at 14.00 as E-Meeting, the meeting passed several resolutions that impact the company's operations and shareholder rights. The voting results demonstrate unanimous support from shareholders, with all resolutions being approved without any opposing votes.

Key Takeaways:

• The Extraordinary General Meeting of Shareholders No. 3/2025 was held on September 19, 2025, with a total voting right of 1,389,232,270.
• Agenda 1: The meeting approved the minutes of the Extraordinary General Meeting of Shareholders No. 2/2025 with 1,389,232,270 votes in favor, 0 votes against, and 0 abstentions.
• Agenda 2: The meeting cancelled the resolutions from the Extraordinary General Meeting of Shareholders No. 2/2025 for agendas 2 through 5, including changes in par value, reduction of registered capital, increase of registered capital, and allocation of new shares under a General Mandate.
• The cancellations align with the change in par value of the Company's shares, reduction of the Company's registered capital, increase of the Company's registered capital, and cancellation of related actions.
• The complete document outlining the meeting's resolutions and voting results can be viewed at the provided link: https://www.set.or.th/en/home.

Statistics:

• 1,389,232,270: The total voting right of shareholders who attended the meeting and had the right to vote.
• 100.0000: The percentage of votes in favor of Agenda 1, representing 100% approved votes.
• 0: The number of opposing votes and abstained votes for Agenda 1.

Sources:

• Stock Exchange of Thailand, "Company Announcement: Madame Bioscience Public Company Limited".